{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:48:52Z","timestamp":1791643732042,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003787","name":"Hebei Natural Science Foundation","doi-asserted-by":"crossref","award":["H2022206483"],"award-info":[{"award-number":["H2022206483"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"crossref"}]},{"name":"S&T Program of Hebei","award":["22377711D"],"award-info":[{"award-number":["22377711D"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s12035-024-04072-0","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T06:01:52Z","timestamp":1709791312000},"page":"7989-7999","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Interferon Regulatory Factor 5 Gene Polymorphisms and mRNA Expression Levels Are Associated with Neuromyelitis Optica Spectrum Disorder"],"prefix":"10.1007","volume":"61","author":[{"given":"Gaoning","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshad","family":"Mehmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huining","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"issue":"1","key":"4072_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41572-020-0214-9","volume":"6","author":"S Jarius","year":"2020","unstructured":"Jarius S, Paul F, Weinshenker BG, Levy M, Kim HJ, Wildemann B (2020) Neuromyelitis Optica. Nat Reviews Disease Primers 6(1):85. https:\/\/doi.org\/10.1038\/s41572-020-0214-9","journal-title":"Nat Reviews Disease Primers"},{"key":"4072_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1742-2094-10-8","volume":"10","author":"S Jarius","year":"2013","unstructured":"Jarius S, Wildemann B (2013) The history of neuromyelitis optica. J Neuroinflamm 10:8. https:\/\/doi.org\/10.1186\/1742-2094-10-8","journal-title":"J Neuroinflamm"},{"key":"4072_CR3","doi-asserted-by":"publisher","first-page":"116396","DOI":"10.1016\/j.jns.2019.07.014","volume":"407","author":"S Jarius","year":"2019","unstructured":"Jarius S, Wildemann B (2019) Devic\u2019s index case: a critical reappraisal - AQP4-IgG-mediated neuromyelitis optica spectrum disorder, or rather MOG encephalomyelitis? J Neurol Sci 407:116396. https:\/\/doi.org\/10.1016\/j.jns.2019.07.014","journal-title":"J Neurol Sci"},{"issue":"9","key":"4072_CR4","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/s1474-4422(07)70216-8","volume":"6","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6(9):805\u2013815. https:\/\/doi.org\/10.1016\/s1474-4422(07)70216-8","journal-title":"Lancet Neurol"},{"key":"4072_CR5","doi-asserted-by":"publisher","unstructured":"Bennett JL, O\u2019Connor KC, Bar-Or A, Zamvil SS, Hemmer B, Tedder TF, von B\u00fcdingen HC, Stuve O, Yeaman MR, Smith TJ, Stadelmann C (2015) B lymphocytes in neuromyelitis optica. Neurology(R) neuroimmunology & neuroinflammation 2 (3):e104. https:\/\/doi.org\/10.1212\/nxi.0000000000000104","DOI":"10.1212\/nxi.0000000000000104"},{"issue":"5","key":"4072_CR6","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1084\/jem.20111675","volume":"209","author":"TA Barr","year":"2012","unstructured":"Barr TA, Shen P, Brown S, Lampropoulou V, Roch T, Lawrie S, Fan B, O\u2019Connor RA, Anderton SM, Bar-Or A, Fillatreau S, Gray D (2012) B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J Exp Med 209(5):1001\u20131010. https:\/\/doi.org\/10.1084\/jem.20111675","journal-title":"J Exp Med"},{"issue":"S1","key":"4072_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar3907","volume":"15","author":"I Kalampokis","year":"2013","unstructured":"Kalampokis I, Yoshizaki A, Tedder TF (2013) IL-10-producing regulatory B cells (B10 cells) in autoimmune disease. Arthritis Res Therapy 15(S1):1\u201312. https:\/\/doi.org\/10.1186\/ar3907","journal-title":"Arthritis Res Therapy"},{"issue":"4","key":"4072_CR8","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1212\/WNL.0b013e3181ea9f15","volume":"75","author":"M Matiello","year":"2010","unstructured":"Matiello M, Kim HJ, Kim W, Brum DG, Barreira AA, Kingsbury DJ, Plant GT, Adoni T, Weinshenker BG (2010) Familial neuromyelitis optica. Neurology 75(4):310\u2013315. https:\/\/doi.org\/10.1212\/WNL.0b013e3181ea9f15","journal-title":"Neurology"},{"issue":"2","key":"4072_CR9","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1212\/wnl.55.2.318","volume":"55","author":"K Yamakawa","year":"2000","unstructured":"Yamakawa K, Kuroda H, Fujihara K, Sato S, Nakashima I, Takeda A, Suzuki K, Itoyama Y (2000) Familial neuromyelitis optica (Devic\u2019s syndrome) with late onset in Japan. Neurology 55(2):318\u2013320. https:\/\/doi.org\/10.1212\/wnl.55.2.318","journal-title":"Neurology"},{"key":"4072_CR10","doi-asserted-by":"publisher","unstructured":"Bruijstens AL, Wong YYM, van Pelt DE, van der Linden PJE, Haasnoot GW, Hintzen RQ, Claas FHJ, Neuteboom RF, Wokke BHA (2020) HLA association in MOG-IgG- and AQP4-IgG-related disorders of the CNS in the Dutch population. Neurology(R) Neuroimmunol Neuroinflammation 7(3). https:\/\/doi.org\/10.1212\/nxi.0000000000000702","DOI":"10.1212\/nxi.0000000000000702"},{"issue":"1","key":"4072_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/1871524916666160229115047","volume":"18","author":"VR Alonso","year":"2018","unstructured":"Alonso VR, de Jesus Flores Rivera J, Garci YR, Granados J, Sanchez T, Mena-Hernandez L, Corona T (2018) Neuromyelitis Optica (NMO IgG+) and genetic susceptibility, potential ethnic influences. Cent Nerv Syst Agents Med Chem 18(1):4\u20137. https:\/\/doi.org\/10.2174\/1871524916666160229115047","journal-title":"Cent Nerv Syst Agents Med Chem"},{"issue":"9","key":"4072_CR12","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1177\/1352458515574149","volume":"21","author":"L Pandit","year":"2015","unstructured":"Pandit L, Malli C, D\u2019Cunha A, Mustafa S (2015) Human leukocyte antigen association with neuromyelitis optica in a south Indian population. Mult Scler 21(9):1217\u20131218. https:\/\/doi.org\/10.1177\/1352458515574149","journal-title":"Mult Scler"},{"issue":"1","key":"4072_CR13","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12974-019-1551-z","volume":"16","author":"K Ogawa","year":"2019","unstructured":"Ogawa K, Okuno T, Hosomichi K, Hosokawa A, Hirata J, Suzuki K, Sakaue S, Kinoshita M, Asano Y, Miyamoto K, Inoue I, Kusunoki S, Okada Y, Mochizuki H (2019) Next-generation sequencing identifies contribution of both class I and II HLA genes on susceptibility of multiple sclerosis in Japanese. J Neuroinflamm 16(1):162. https:\/\/doi.org\/10.1186\/s12974-019-1551-z","journal-title":"J Neuroinflamm"},{"issue":"1\u20132","key":"4072_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jneuroim.2010.11.004","volume":"233","author":"H Wang","year":"2011","unstructured":"Wang H, Dai Y, Qiu W, Zhong X, Wu A, Wang Y, Lu Z, Bao J, Hu X (2011) HLA-DPB1 0501 is associated with susceptibility to anti-aquaporin-4 antibodies positive neuromyelitis optica in southern Han Chinese. J Neuroimmunol 233(1\u20132):181\u2013184. https:\/\/doi.org\/10.1016\/j.jneuroim.2010.11.004","journal-title":"J Neuroimmunol"},{"key":"4072_CR15","doi-asserted-by":"publisher","unstructured":"Negishi H, Taniguchi T, Yanai H (2018) The Interferon (IFN) Class of cytokines and the IFN Regulatory Factor (IRF) transcription factor family. Cold Spring Harb Perspect Biol 10(11). https:\/\/doi.org\/10.1101\/cshperspect.a028423","DOI":"10.1101\/cshperspect.a028423"},{"issue":"2","key":"4072_CR16","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.cellimm.2011.07.014","volume":"271","author":"SE Sweeney","year":"2011","unstructured":"Sweeney SE (2011) Targeting interferon regulatory factors to inhibit activation of the type I IFN response: implications for treatment of autoimmune disorders. Cell Immunol 271(2):342\u2013349. https:\/\/doi.org\/10.1016\/j.cellimm.2011.07.014","journal-title":"Cell Immunol"},{"issue":"10","key":"4072_CR17","doi-asserted-by":"publisher","first-page":"6003","DOI":"10.4049\/jimmunol.1000482","volume":"185","author":"D Feng","year":"2010","unstructured":"Feng D, Sangster-Guity N, Stone R, Korczeniewska J, Mancl ME, Fitzgerald-Bocarsly P, Barnes BJ (2010) Differential requirement of histone acetylase and deacetylase activities for IRF5-mediated proinflammatory cytokine expression. J Immunol 185(10):6003\u20136012. https:\/\/doi.org\/10.4049\/jimmunol.1000482","journal-title":"J Immunol"},{"issue":"7030","key":"4072_CR18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nature03308","volume":"434","author":"A Takaoka","year":"2005","unstructured":"Takaoka A, Yanai H, Kondo S, Duncan G, Negishi H, Mizutani T, Kano S, Honda K, Ohba Y, Mak TW, Taniguchi T (2005) Integral role of IRF-5 in the gene induction programme activated by toll-like receptors. Nature 434(7030):243\u2013249. https:\/\/doi.org\/10.1038\/nature03308","journal-title":"Nature"},{"key":"4072_CR19","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1146\/annurev.immunol.26.021607.090400","volume":"26","author":"T Tamura","year":"2008","unstructured":"Tamura T, Yanai H, Savitsky D, Taniguchi T (2008) The IRF family transcription factors in immunity and oncogenesis. Annu Rev Immunol 26:535\u2013584. https:\/\/doi.org\/10.1146\/annurev.immunol.26.021607.090400","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"4072_CR20","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/ng1782","volume":"38","author":"RR Graham","year":"2006","unstructured":"Graham RR, Kozyrev SV, Baechler EC, Reddy MV, Plenge RM, Bauer JW, Ortmann WA, Koeuth T, Gonz\u00e1lez Escribano MF, Pons-Estel B, Petri M, Daly M, Gregersen PK, Mart\u00edn J, Altshuler D, Behrens TW, Alarc\u00f3n-Riquelme ME (2006) A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 38(5):550\u2013555. https:\/\/doi.org\/10.1038\/ng1782","journal-title":"Nat Genet"},{"issue":"3","key":"4072_CR21","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1086\/428480","volume":"76","author":"S Sigurdsson","year":"2005","unstructured":"Sigurdsson S, Nordmark G, G\u00f6ring HH, Lindroos K, Wiman AC, Sturfelt G, J\u00f6nsen A, Rantap\u00e4\u00e4-Dahlqvist S, M\u00f6ller B, Kere J, Koskenmies S, Wid\u00e9n E, Eloranta ML, Julkunen H, Kristjansdottir H, Steinsson K, Alm G, R\u00f6nnblom L, Syv\u00e4nen AC (2005) Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 76(3):528\u2013537. https:\/\/doi.org\/10.1086\/428480","journal-title":"Am J Hum Genet"},{"issue":"5","key":"4072_CR22","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1212\/wnl.0000000000002366","volume":"86","author":"CT Tan","year":"2016","unstructured":"Tan CT, Mao Z, Qiu W, Hu X, Wingerchuk DM, Weinshenker BG (2016) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 86(5):491\u2013492. https:\/\/doi.org\/10.1212\/wnl.0000000000002366","journal-title":"Neurology"},{"issue":"1","key":"4072_CR23","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1186\/s12913-017-2807-x","volume":"17","author":"A Sicras-Mainar","year":"2017","unstructured":"Sicras-Mainar A, Ru\u00edz-Beato E, Navarro-Artieda R, Maurino J (2017) Impact on healthcare resource utilization of multiple sclerosis in Spain. BMC Health Serv Res 17(1):854. https:\/\/doi.org\/10.1186\/s12913-017-2807-x","journal-title":"BMC Health Serv Res"},{"key":"4072_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-023-00805-3","author":"YY Shi","year":"2023","unstructured":"Shi YY, He L (2023) Publisher correction: SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. https:\/\/doi.org\/10.1038\/s41422-023-00805-3","journal-title":"Cell Res"},{"issue":"1","key":"4072_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00414-016-1490-5","volume":"131","author":"B Mehta","year":"2017","unstructured":"Mehta B, Daniel R, Phillips C, McNevin D (2017) Forensically relevant SNaPshot(\u00ae) assays for human DNA SNP analysis: a review. Int J Legal Med 131(1):21\u201337. https:\/\/doi.org\/10.1007\/s00414-016-1490-5","journal-title":"Int J Legal Med"},{"issue":"9","key":"4072_CR26","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/nri1900","volume":"6","author":"K Honda","year":"2006","unstructured":"Honda K, Taniguchi T (2006) IRFs: master regulators of signalling by toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6(9):644\u2013658. https:\/\/doi.org\/10.1038\/nri1900","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"4072_CR27","doi-asserted-by":"publisher","first-page":"4473","DOI":"10.4238\/2014.June.16.6","volume":"13","author":"L Tang","year":"2014","unstructured":"Tang L, Chen B, Ma B, Nie S (2014) Association between IRF5 polymorphisms and autoimmune diseases: a meta-analysis. Genet Mol Research: GMR 13(2):4473\u20134485. https:\/\/doi.org\/10.4238\/2014.June.16.6","journal-title":"Genet Mol Research: GMR"},{"issue":"10","key":"4072_CR28","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s00011-015-0865-2","volume":"64","author":"L Tang","year":"2015","unstructured":"Tang L, Wan P, Wang Y, Pan J, Wang Y, Chen B (2015) Genetic association and interaction between the IRF5 and TYK2 genes and systemic lupus erythematosus in the Han Chinese population. Inflamm Research: Official J Eur Histamine Res Soc [et al] 64(10):817\u2013824. https:\/\/doi.org\/10.1007\/s00011-015-0865-2","journal-title":"Inflamm Research: Official J Eur Histamine Res Soc [et al]"},{"issue":"6","key":"4072_CR29","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1093\/hmg\/ddm359","volume":"17","author":"S Sigurdsson","year":"2008","unstructured":"Sigurdsson S, G\u00f6ring HH, Kristjansdottir G, Milani L, Nordmark G, Sandling JK, Eloranta ML, Feng D, Sangster-Guity N, Gunnarsson I, Svenungsson E, Sturfelt G, J\u00f6nsen A, Truedsson L, Barnes BJ, Alm G, R\u00f6nnblom L, Syv\u00e4nen AC (2008) Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5\u00a0bp length polymorphism as strong risk factor for systemic lupus erythematosus. Hum Mol Genet 17(6):872\u2013881. https:\/\/doi.org\/10.1093\/hmg\/ddm359","journal-title":"Hum Mol Genet"},{"issue":"5","key":"4072_CR30","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1744-313X.2011.01025.x","volume":"38","author":"W Hu","year":"2011","unstructured":"Hu W, Ren H (2011) A meta-analysis of the association of IRF5 polymorphism with systemic lupus erythematosus. Int J Immunogenet 38(5):411\u2013417. https:\/\/doi.org\/10.1111\/j.1744-313X.2011.01025.x","journal-title":"Int J Immunogenet"},{"issue":"3","key":"4072_CR31","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/annrheumdis-2011-200463","volume":"71","author":"TB Niewold","year":"2012","unstructured":"Niewold TB, Kelly JA, Kariuki SN, Franek BS, Kumar AA, Kaufman KM, Thomas K, Walker D, Kamp S, Frost JM, Wong AK, Merrill JT, Alarc\u00f3n-Riquelme ME, Tikly M, Ramsey-Goldman R, Reveille JD, Petri MA, Edberg JC, Kimberly RP, Alarc\u00f3n GS, Kamen DL, Gilkeson GS, Vyse TJ, James JA, Gaffney PM, Moser KL, Crow MK, Harley JB (2012) IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus. Ann Rheum Dis 71(3):463\u2013468. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200463","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"4072_CR32","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1136\/jmg.2007.055012","volume":"45","author":"G Kristjansdottir","year":"2008","unstructured":"Kristjansdottir G, Sandling JK, Bonetti A, Roos IM, Milani L, Wang C, Gustafsdottir SM, Sigurdsson S, Lundmark A, Tienari PJ, Koivisto K, Elovaara I, Pirttil\u00e4 T, Reunanen M, Peltonen L, Saarela J, Hillert J, Olsson T, Landegren U, Alcina A, Fern\u00e1ndez O, Leyva L, Guerrero M, Lucas M, Izquierdo G, Matesanz F, Syv\u00e4nen AC (2008) Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. J Med Genet 45(6):362\u2013369. https:\/\/doi.org\/10.1136\/jmg.2007.055012","journal-title":"J Med Genet"},{"issue":"13","key":"4072_CR33","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.4103\/0366-6999.159347","volume":"128","author":"QB Liu","year":"2015","unstructured":"Liu QB, Wu L, Zhao GX, Cai PP, Li ZX, Wu ZY (2015) Variants of interferon regulatory factor 5 are associated with neither neuromyelitis optica nor multiple sclerosis in the southeastern Han Chinese population. Chin Med J 128(13):1743\u20131747. https:\/\/doi.org\/10.4103\/0366-6999.159347","journal-title":"Chin Med J"},{"issue":"12","key":"4072_CR34","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1111\/cns.13738","volume":"27","author":"BW Yin","year":"2021","unstructured":"Yin BW, Li B, Mehmood A, Yuan C, Song S, Guo RY, Zhang L, Ma T, Guo L (2021) BLK polymorphisms and expression level in neuromyelitis optica spectrum disorder. CNS Neurosci Ther 27(12):1549\u20131560. https:\/\/doi.org\/10.1111\/cns.13738","journal-title":"CNS Neurosci Ther"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04072-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-04072-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04072-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T09:27:02Z","timestamp":1726824422000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-04072-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,7]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["4072"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-04072-0","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,7]]},"assertion":[{"value":"22 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experiments were performed at the Key Laboratory of Neurology of Hebei Province and were approved by the Experimental Ethics Committee of the Second Hospital of Hebei Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Before this study, all participants gave informed written consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}